Wells Fargo Maintains Overweight on Adient, Raises Price Target to $32
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and raises the price target from $28 to $32.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and raises the price target from $28 to $32.